SPRB Spruce Biosciences, Inc. Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
14:57
Nov 09
seedy19tron
SPRB faces cash crunch, sale expected
SPRB is running out of cash and a sale is expected, a bearish cash-runway outcome for the stock.
SPRB Spruce Biosciences, Inc. Avoid — —
22:29
Oct 06
aleabitoreddit
SPRB upside, high dilution risk
Expects Spruce Biosciences to keep rising from a $75m to a $150-$200m market cap. He calls the trade Russian Roulette because dilution usually comes 2-3 days after a major event.
SPRB Spruce Biosciences, Inc. Long — —
20:19
Oct 06
aleabitoreddit
High-risk SPRB bet on TA-ERT approval
Bought $50k of SPRB as a high-risk gamble. If TA-ERT is approved and wins 10-15% of a $1.4B US market ($180-270M ARR), fair value could be about $280M-630M at 2-3x revenue, versus an $85M market cap. Clinical, commercialization and dilution risks remain.
SPRB Spruce Biosciences, Inc. Long 1ST Position: Opened —

About SPRB Investor Commentary

Across the available history and selected sources, Buzzberg tracks SPRB (Spruce Biosciences, Inc.) across 2 sources: 2 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 33% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 6 total trade ideas tracked. Past 7 days, before deduplication: 2 other directions. Latest voices: seedy19tron, aleabitoreddit.